Back

Unbiased Assessment of H-STS cells as high-fidelity models for gastro-enteropancreatic neuroendocrine tumor drug mechanism of action analysis

Alvarez, M. J.; Yan, P.; Alpaugh, M. L.; Bowden, M.; Sicinska, E.; Zhou, C. W.; Karan, C.; Realubit, R. B.; Mundi, P. S.; Grunn, A.; Jäger, D.; Chabot, J. A.; Fojo, A. T.; Oberstein, P. E.; Hibshoosh, H.; Milsom, J. W.; Kulke, M. H.; Loda, M.; Chiosis, G.; Reidy-Lagunes, D. L.; Califano, A.

2019-06-23 cancer biology
10.1101/677435 bioRxiv
Show abstract

Quantitative metrics to objectively assess the fidelity of cancer models, such as cell lines, organoids, or patient-derived xenografts (PDXs), remain elusive, with histological criteria or the presence of specific mutations often used as driving principles. We show that molecular criteria, based on the regulatory proteins responsible for maintaining transcriptional cell state and its regulatory network, are effective in identifying models that can recapitulate drug mechanism of action and drug sensitivity, independent of histological consideration.

Matching journals

The top 9 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.